Ascend Wellness Launches New Edibles Brand ‘Effin”: Targeting Specific Effects with Unique Formulations

Ascend Wellness Holdings, a vertically integrated cannabis operator, announced the launch of its new edibles-only brand, ‘Effin’. The brand focuses on delivering specific effects through expertly formulated combinations of THC and minor cannabinoids. Effin’ initially debuted in Massachusetts and Illinois and is set to launch in New Jersey soon, offering unique SKUs targeting chill, sleep, focus, and energy.

US Veteran Arrested in Dubai Over Prescription CBD: A Cautionary Tale of Strict Laws

A retired Navy veteran from Georgia, Charles Wimberly, faces an uncertain legal situation in Dubai after being arrested for possessing medically prescribed CBD pills. Despite presenting his prescription, authorities accused him of drug trafficking, highlighting the strict laws against CBD in the UAE. Wimberly’s family and legal advocates are seeking his release, emphasizing the potential health risks associated with his detainment and the unclear legal grounds for his arrest.

Rachel Sennott Arrested in Cayman Islands for CBD, Shares Hilarious Story on ‘The Tonight Show’

Actress Rachel Sennott, known for her role in ‘Bottoms,’ found herself in an unexpected situation during a recent trip to the Cayman Islands. She was arrested for possessing CBD, which is legal in the US but not in the islands. Sennott recounted the experience on ‘The Tonight Show’ with Jimmy Fallon, sharing the humorous details of her arrest and subsequent release.

Cannabinoids Show Promise in Cancer Treatment: Research Highlights Potential and Challenges

Recent research has unveiled the potential anticancer properties of cannabinoids like THC, CBD, and CBG, sparking optimism for their role in inhibiting tumor growth and improving palliative care. However, despite promising findings, challenges remain in understanding their mechanisms and translating these discoveries into effective clinical applications. The article explores the potential benefits, research gaps, and regulatory hurdles hindering wider adoption of cannabinoids in cancer treatment.

Scroll to Top